Bellicum Pharmaceuticals Price History

BLCMDelisted Stock  USD 0.37  0.05  11.90%   
If you're considering investing in Bellicum Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Bellicum Pharmaceuticals stands at 0.37, as last reported on the 2nd of December, with the highest price reaching 0.44 and the lowest price hitting 0.37 during the day. We have found twenty-nine technical indicators for Bellicum Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please confirm Bellicum Pharmaceuticals' Risk Adjusted Performance of 0.0421, downside deviation of 16.04, and Mean Deviation of 12.36 to double-check if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Bellicum Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
BLCM
Based on monthly moving average Bellicum Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bellicum Pharmaceuticals by adding Bellicum Pharmaceuticals to a well-diversified portfolio.

Bellicum Pharmaceuticals Pink Sheet Price History Chart

There are several ways to analyze Bellicum Stock price data. The simplest method is using a basic Bellicum candlestick price chart, which shows Bellicum Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.

Bellicum Pink Sheet Price History Data

The price series of Bellicum Pharmaceuticals for the period between Tue, Sep 3, 2024 and Mon, Dec 2, 2024 has a statistical range of 0.73 with a coefficient of variation of 46.79. The prices are distributed with arithmetic mean of 0.51. The median price for the last 90 days is 0.4. The company had 1:10 stock split on 6th of February 2020. Bellicum Pharmaceuticals issued dividends on 2020-02-06.
OpenHighLowCloseVolume
12/02/2024
 0.42  0.44  0.37  0.37 
06/09/2023 0.42  0.44  0.37  0.37  19,100 
06/08/2023 0.44  0.52  0.38  0.44  67,400 
06/07/2023 0.25  0.49  0.23  0.44  325,600 
06/06/2023 0.23  0.28  0.21  0.25  232,066 
06/05/2023 0.25  0.36  0.18  0.23  720,093 
06/02/2023 0.40  0.53  0.15  0.30  229,300 
06/01/2023 0.67  0.70  0.62  0.62  259,934 
05/31/2023 0.65  0.73  0.65  0.69  369,600 
05/30/2023 0.75  0.78  0.74  0.77  192,600 
05/26/2023 0.78  0.79  0.72  0.78  93,700 
05/25/2023 0.81  0.81  0.75  0.76  78,736 
05/24/2023 0.76  0.80  0.75  0.79  71,200 
05/23/2023 0.80  0.80  0.76  0.80  82,991 
05/22/2023 0.81  0.81  0.76  0.81  171,200 
05/19/2023 0.80  0.80  0.76  0.79  191,184 
05/18/2023 0.84  0.84  0.75  0.76  251,678 
05/17/2023 0.80  0.85  0.75  0.84  265,800 
05/16/2023 0.79  0.83  0.73  0.79  216,098 
05/15/2023 0.75  0.82  0.74  0.80  294,214 
05/12/2023 0.72  0.78  0.72  0.75  343,600 
05/11/2023 0.78  0.82  0.72  0.80  769,356 
05/10/2023 0.78  0.88  0.70  0.82  1,951,460 
05/09/2023 0.81  0.81  0.67  0.78  4,960,582 
05/08/2023 1.15  1.31  0.88  0.96  100,431,164 
05/05/2023 0.38  0.41  0.36  0.40  131,392 
05/04/2023 0.37  0.38  0.36  0.38  98,600 
05/03/2023 0.38  0.38  0.34  0.38  91,000 
05/02/2023 0.36  0.38  0.35  0.37  197,700 
05/01/2023 0.37  0.37  0.34  0.36  159,616 
04/28/2023 0.33  0.37  0.32  0.35  364,591 
04/27/2023 0.38  0.54  0.34  0.42  4,571,343 
04/26/2023 0.36  0.37  0.34  0.34  95,767 
04/25/2023 0.35  0.36  0.33  0.34  232,193 
04/24/2023 0.33  0.36  0.31  0.34  103,600 
04/21/2023 0.38  0.41  0.32  0.34  316,789 
04/20/2023 0.39  0.42  0.36  0.39  433,714 
04/19/2023 0.48  0.58  0.41  0.42  2,617,221 
04/18/2023 0.44  0.54  0.39  0.52  3,652,210 
04/17/2023 0.28  1.07  0.28  0.57  49,995,039 
04/14/2023 0.29  0.32  0.28  0.28  134,010 
04/13/2023 0.28  0.31  0.28  0.29  38,100 
04/12/2023 0.28  0.30  0.28  0.30  4,630 
04/11/2023 0.29  0.31  0.29  0.29  25,871 
04/10/2023 0.30  0.32  0.28  0.30  85,893 
04/06/2023 0.29  0.32  0.29  0.30  69,495 
04/05/2023 0.31  0.32  0.28  0.29  21,357 
04/04/2023 0.31  0.34  0.30  0.31  35,672 
04/03/2023 0.32  0.34  0.29  0.32  106,477 
03/31/2023 0.31  0.36  0.31  0.33  202,248 
03/30/2023 0.30  0.32  0.29  0.30  55,687 
03/29/2023 0.28  0.31  0.25  0.28  105,040 
03/28/2023 0.25  0.28  0.25  0.26  57,745 
03/27/2023 0.28  0.29  0.24  0.27  252,153 
03/24/2023 0.28  0.29  0.23  0.28  429,824 
03/23/2023 0.32  0.33  0.27  0.30  243,554 
03/22/2023 0.31  0.34  0.28  0.29  157,349 
03/21/2023 0.31  0.35  0.27  0.32  399,086 
03/20/2023 0.40  0.40  0.29  0.32  122,844 
03/17/2023 0.44  0.44  0.39  0.40  286,315 
03/16/2023 0.43  0.46  0.40  0.45  171,348 

About Bellicum Pharmaceuticals Pink Sheet history

Bellicum Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Bellicum is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Bellicum Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Bellicum Pharmaceuticals stock prices may prove useful in developing a viable investing in Bellicum Pharmaceuticals
Bellicum Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological cancers and solid tumors in the United States and internationally. Bellicum Pharmaceuticals, Inc. was incorporated in 2004 and is headquartered in Houston, Texas. Bellicum Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 7 people.

Bellicum Pharmaceuticals Pink Sheet Technical Analysis

Bellicum Pharmaceuticals technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
A focus of Bellicum Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Bellicum Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Balance Of Power Now

   

Balance Of Power

Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
All  Next Launch Module

Bellicum Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Bellicum Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Bellicum Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of Bellicum to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Consideration for investing in Bellicum Pink Sheet

If you are still planning to invest in Bellicum Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bellicum Pharmaceuticals' history and understand the potential risks before investing.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.